Identification of Potential Diagnostic and Vaccine Candidates of Helicobacter pylori by Two-Dimensional Gel Electrophoresis, Sequence Analysis, and Serum Profiling

There is great interest in characterizing the proteins of the gastric pathogen Helicobacter pylori, especially those to which humans respond immunologically, because of the potential importance of such proteins in diagnosis and vaccine development. Two-dimensional gel electrophoresis was used to separate and identify potential antigens of H. pylori ATCC 43504. Over 30 proteins were reactive in Western blots with pooled sera from 14 infected patients. These proteins were analyzed by N-terminal sequence analysis. Fourteen proteins were determined to be distinct from any proteins previously described from H. pylori; the others were previously isolated and characterized proteins. Analysis of eight distinct H. pylori strains showed that most of these antigens were produced by all of the strains. We propose that collection of new antigens such as those recognized here will be useful in serologic tests for detecting and monitoring H. pylori infection and may also serve as potential targets for antimicrobial agent or vaccine development.     

Mitochondrial Antibodies in Primary Biliary Cirrhosis: II. The Complement Fixing Antigen as a Component of Mitochondrial Inner Membranes

The autoantibodies found in the sera of patients with primary biliary cirrhosis have been shown to react with a component of the mitochondrial inner membranes. Outer membranes were inactive. The purity of the inner and outer membrane fractions obtained by 2 different methods was assessed by electron microscopy and marker enzyme tests. Using negative-staining it was possible to visualize antibody binding to mitochondrial membranes. At high resolution it could be seen that the 90° particles on the cristal membranes were not involved in the reaction with antibody, but it was not possible to establish in the present studies the precise antigenic site upon the mitochondrial inner membranes.     

Human smooth pursuit during transient perturbations of predictable and unpredictable target movement

Summary The predictive component of human smooth pursuit was studied by perturbing sinusoidal target motion at unpredictable instants. The disturbances consisted of either a brief period of stabilization of the target on the fovea or a replacement of the sine by a ramp displacement for half a period. To minimize the effects of a possible change of the tracking strategy by the subject the transitions were masked and only the initial part of the response to the disturbance was analyzed. After stabilization on the fovea the eye oscillation continued at the frequency of the preceding target movement for about one half-cycle, whereupon the oscillation was rapidly damped. The mean unidirectional smooth eye acceleration was 70% of the mean unidirectional target acceleration prior to the stabilization. This suggests that during pursuit of a sinusoidal target movement about 75% of the oculomotor response is generated by predictive processes. When the sine was replaced by a ramp, starting at the velocity zero-crossing, the eye accelerated away from the target for ca. 180 ms irrespective of the frequency of prior tracking. In contrast, when the ramp started at the peak velocity of the sinusoidal target motion the eye accelerated away from the target for more than a quarter period. After foveal stabilization during pursuit of a pseudorandom stimulus, the eye continued to oscillate for less than one period at approximately the highest frequency present in the stimulus. The frequency characteristics of human smooth pursuit of predictable as well as unpredictable target motion were correctly simulated by a model, which derived its predictive properties from a lead element, tuned to the current frequency of the target motion.     

Recombination factors for the cylindrical FC65-G ionization chamber in pulsed photon beams and the plane-parallel Roos ionization chamber in pulsed electron beams

The use of ionization chambers in linac radiotherapy dosimetry requires various corrections to the measured charges, one of these being the recombination correction. The recombination correction factor (k(s)) is generally estimated from the two-voltage analysis (TVA) for each beam quality. However, it is possible that the ionization chamber above some threshold polarizing voltage does not follow the accepted Boag theory very well. Secondly the TVA is time-consuming as the chamber needs to stabilize after each polarizing voltage change and since it must be performed for each beam quality. Another approach consists in using the fact that k(s) is predicted to depend linearly on dose per pulse by Boag theory: determining this relationship once and for all using a multi-voltage analysis (MVA), one also checks the range validity of the Boag theory for the chamber considered. This work presents a thorough analysis of k(s) dependence on dose per pulse of FC65-G (cylindrical) and Roos (plane-parallel) ionization chambers in pulsed photon and electron beams, respectively. Within the uncertainties, the recombination factors are found to be independent of beam quality, and no deviation from the Boag theory is observed within the tested range of polarizing voltages. Before adapting the equations given using the MVA other users should check that their ionization chambers show the same dose per pulse dependence using the TVA for a few beam qualities.     

Cardiovascular risk factors in people with different genotypes in the insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme (ACE)

The deletion (D) allele of an insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme (ACE) has been reported to be an independent risk factor for myocardial infarction (MI), particularly in people lacking traditional risk factors. Furthermore, a borderline association between Lp(a) lipoprotein level and the I/D polymorphism at the ACE locus was reported in one study. We have searched for possible "level gene" or "variability gene" effects of ACE genes on Lp(a) lipoprotein, total cholesterol (TC), high density lipoprotein (HDL) cholesterol (HDLC), low density lipoprotein (LDL) cholesterol (LDLC), triglycerides (TG), apolipoprotein B (apoB), apolipoprotein A-I (apoA-I), and body mass index (BMI). None of these variables differed significantly between genotypes in the I/D polymorphism in any of three population samples. A single population sample created by combining the three series, exhibited an insignificant trend towards individuals carrying the D-allele having a higher level of Lp(a) lipoprotein than those lacking it, and DD homozygotes had a significantly higher Lp(a) lipoprotein level than the combined group of ID/II individuals (p = 0.03). These results may indicate that the D-allele of the I/D polymorphism at the ACE locus could influence the level of Lp(a) lipoprotein.     

High levels of Lp(a) lipoprotein in a family ith cases of severe pre-eclampsia

We report a family with two cases of severe pre-eclampsia/eclampsia in which very high levels of Lp(a) lipoprotein were found. The serum level of Lp(a) lipoprotein is genetically determined and the Lp(a) apolipoprotein has a close homology to plasminogen. Very high levels of Lp(a) lipoprotein might interfere with the fibrinolytic/thrombolytic process in man. A previous report suggested that a high maternal serum Lp(a) lipoprotein level can cause fetal growth retardation, and it is proposed that very high levels might lead to increased deposition of fibrin in the uterine spiral arteries in pregnancy, which is central in the pathogenesis of pre-eclampsia. If confirmed, a very high Lp(a) lipoprotein level could be one risk factor for pre-eclampsia that is genetically determined.     

Restriction site polymorphism at the LPA (Lp(a) apoliprotein; apoliprotein(a)) locus

A restriction site polymorphism in the Lp(a) apolipoprotein gene (the LPA gene) is reported. The basis for the polymorphism is presence or absence of an MspI restriction site that appears to be 3' to the last kringle IV structure of the gene. The "1" gene (presence of the restriction site) has a frequency of 0.316 and the "2" gene (absence of the restriction site) has a frequency of 0.684. Both members of each of 67 monozygotic (MZ) twin pairs had the same genotype and there was Mendelian segregation of the DNA variants in 40 families with a total of 75 children. There was a lower proportion of people with genotype 1-1 in the top quartile than in the 3 bottom quartiles of the population distribution of Lp(a) lipoprotein levels but the difference did not reach statistical significance.